Cargando…
Blockade of PLD2 Ameliorates Intestinal Mucosal Inflammation of Inflammatory Bowel Disease
Background. Inflammatory bowel diseases (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), are chronically remittent and progressive inflammatory disorders. Phospholipase D2 (PLD2) is reported to be involved in the pathogenesis of several inflammatory diseases. However, the exac...
Autores principales: | Zhou, Guangxi, Yu, Lin, Yang, Wenjing, Wu, Wei, Fang, Leilei, Liu, Zhanju |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5046040/ https://www.ncbi.nlm.nih.gov/pubmed/27721573 http://dx.doi.org/10.1155/2016/2543070 |
Ejemplares similares
-
Anti-TNF-α Therapy Suppresses Proinflammatory Activities of Mucosal Neutrophils in Inflammatory Bowel Disease
por: Zhang, Cui, et al.
Publicado: (2018) -
Microbiota metabolite butyrate constrains neutrophil functions and ameliorates mucosal inflammation in inflammatory bowel disease
por: Li, Gengfeng, et al.
Publicado: (2021) -
Intestinal epithelial pH-sensing receptor GPR65 maintains mucosal homeostasis via regulating antimicrobial defense and restrains gut inflammation in inflammatory bowel disease
por: Li, Gengfeng, et al.
Publicado: (2023) -
Interplay of intestinal microbiota and mucosal immunity in
inflammatory bowel disease: a relationship of
frenemies
por: Chen, Huimin, et al.
Publicado: (2020) -
Danggui Buxue Decoction Ameliorates Inflammatory Bowel Disease by Improving Inflammation and Rebuilding Intestinal Mucosal Barrier
por: Li, Chengyin, et al.
Publicado: (2021)